Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CADH1 | P12830 | Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3] | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| CADH2 | P19022 | Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325) | CD markersDisease related genesHuman disease related genes | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| CADH3 | P22223 | Cadherin-3 (Placental cadherin) (P-cadherin) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| CADH4 | P55283 | Cadherin-4 (Retinal cadherin) (R-CAD) (R-cadherin) | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| CAHM4 | Q5JW98 | Calcium homeostasis modulator protein 4 (Protein FAM26D) | 4 | Fusion and delivery mediation | 1 | 0.50 | ||||
| CC020 | Q8ND61 | Uncharacterized protein C3orf20 | Predicted intracellular proteins | 1 | Other mediation | 1 | 0.50 | |||
| CCKAR | P32238 | Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R) | 7 | Binge eating disorderBladder disorderDigestive system disease | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| CCR3 | P51677 | C-C chemokine receptor type 3 (C C CKR3) (C-C CKR-3) (CC-CKR-3) (CCR-3) (CCR3) (CKR 3) (CKR3) (Eosinophil eotaxin receptor) (CD antigen CD193) | CD markersG-protein coupled receptorsHuman disease related genes | 7 | AsthmaParkinsonismVasomotor/allergic rhinitis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| CCR9 | P51686 | C-C chemokine receptor type 9 (C-C CKR-9) (CC-CKR-9) (CCR-9) (G-protein coupled receptor 28) (GPR-9-6) (CD antigen CDw199) | CD markersG-protein coupled receptorsPredicted intracellular proteins | 7 | Crohn diseaseSjogren syndromeUlcerative colitis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| CD180 | Q99467 | CD180 antigen (Lymphocyte antigen 64) (Radioprotective 105 kDa protein) (CD antigen CD180) | CD markersPredicted membrane proteins | 1 | Immune mediation | 1 | 0.50 | |||
| CD2 | P06729 | T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | LymphomaPsoriasis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| CD20 | P11836 | B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1) (Bp35) (Leukocyte surface antigen Leu-16) (Membrane-spanning 4-domains subfamily A member 1) (CD antigen CD20) | CD markersDisease related genesFDA approved drug targets | 4 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| CD226 | Q15762 | CD226 antigen (DNAX accessory molecule 1) (DNAM-1) (CD antigen CD226) | CD markersHuman disease related genesPredicted intracellular proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| CD40L | P29965 | CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)] | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | B-cell lymphomaDiabetes mellitusDiffuse large B-cell lymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| CD79B | P40259 | B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b) | Cancer-related genesCD markersDisease related genes | 1 | Autoimmune diseaseDiffuse large B-cell lymphomaFollicular lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | ||
| CD83 | Q01151 | CD83 antigen (hCD83) (B-cell activation protein) (Cell surface protein HB15) (CD antigen CD83) | CD markersPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| CDIPT | O14735 | CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase) | EnzymesMetabolic proteinsPredicted membrane proteins | 6 | Metabolism mediation | 1 | 0.50 | |||
| CEIP2 | Q9UHN6 | Cell surface hyaluronidase CEMIP2 (EC 3.2.1.35) (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.50 | |||
| CELR1 | Q9NYQ6 | Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2) | 7 | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| CKLF7 | Q96FZ5 | CKLF-like MARVEL transmembrane domain-containing protein 7 (Chemokine-like factor superfamily member 7) | 4 | Immune mediation | 1 | 0.50 | ||||
| CLC2A | Q6UVW9 | C-type lectin domain family 2 member A (Keratinocyte-associated C-type lectin) (KACL) (Proliferation-induced lymphocyte-associated receptor) (PILAR) | Predicted membrane proteins | 1 | Immune mediation | 1 | 0.50 | |||
| CLC4F | Q8N1N0 | C-type lectin domain family 4 member F (C-type lectin superfamily member 13) (C-type lectin 13) | 1 | Fusion and delivery mediation | 1 | 0.50 | ||||
| CML2 | P46091 | Chemerin-like receptor 2 (Chemerin chemokine-like receptor 2) (Chemokine-like receptor 2) (G-protein coupled receptor 1) | G-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteins | 7 | Metabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| CNGA4 | Q8IV77 | Cyclic nucleotide-gated channel alpha-4 (CNG channel alpha-4) (CNGa4) (Olfactory cyclic nucleotide-gated channel subunit 2) (OCNC2) | 7 | Fusion and delivery mediation | 1 | 0.50 | ||||
| CNGB1 | Q14028 | Cyclic nucleotide-gated channel beta-1 (CNG channel beta-1) (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Glutamic acid-rich protein) (GARP) | 7 | Fusion and delivery mediationMetabolism mediation | 1 | 0.50 |